Clinical trial
Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure: a Randomized, Placebo-controlled Trial (RISE-HF)
NCT06270498 is registered in ClinicalTrials.gov with Raffaele De Caterina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure: a Randomized, Placebo-controlled Trial (RISE-HF)
- Lead sponsor
- Raffaele De Caterina
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- March 14, 2024
- Completion date
- June 14, 2026
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic heart failure, iron-deficiency, left ventricular systolic dysfunction